Title: Ablatherm HIFU for Prostate Cancer: A 10year European Experience
1Ablatherm - HIFU for Prostate CancerA 10-year
European Experience
A symposium sponsored by
2Salvage High Intensity Focused Ultrasound for
Prostate Cancer Local Relapse After Radiation
Beam Therapy
F-J. Murat, Lyon (FR) Hôpital Edouard Herriot,
Lyon
Ablatherm- HIFU for prostate cancer a 10-year
European experience
A symposium sponsored by
3Local Relapse After RBT How To Affirm it?
- lt2 years post RBT Blind period
- bounce effect PSA non interpretable
- Prostate biopsy non interpretable
- gt2 years post RBT
- Trans-rectal prostate biopsy positive for
cancer - Minimal imaging evaluation negative for
metastasis - Bone CT
- TAP CT
- Prostate MRI
4Local Relapse After RBT An Underestimated
Problem !
- Overall, 30 50 of positive biopsies
- gt 2 years after BRT (1)
- For patients with a rising PSA and a negative
metastatic evaluation - 60 72 of biopsy proven recurrence (2)
(1) Cox, Crook, Pollack, Zagars, Zelefsky (2)
Zagars, Zelefsky
5Local Relapse After RBT A Therapeutical Dilemna!
- Most patients will receive a palliative treatment
with androgen deprivation therapy - However, a local salvage therapy may cure
patients with isolated local relapse
6Local Relapse After RBT
What are the current available options ?
7Local Relapse After RBT Salvage Radical
Prostatectomy
- For surgeons
- A technical challenge
- 5 year biochemical No Evidence of Disease
(5ybNED) 47 65 (1) - Significant complications
- rectal injuries 5 19 (2)
- bladder neck contractures 30 (2)
- urinary incontinence 45 - 68 (3)
- For patients
- High motivation and acceptance of increased
surgicalmorbidity
(1) Amling, Bianco, Gheiler, Stephenson,
Ward (2) Amling, Neerhut, Rogers (3) Gheiler,
Shekarriz, Stephenson, Ward
8Local Relapse After RBT Salvage Cryotherapy
- Technically demanding technique with a long
learning curve - 5ybNED 40 (1)
- Limited capacity for complete prostate
cryoablation - Positive biopsy 14 -37 (2)
- 59 of residual viable benign or malignant
tissue (3) - Complications
- Pelvic pain 18 37 (4)
- Urinary incontinence 9 83 (5)
- Recto-urethral fistula 3.3 3.4 (6)
(4) Long, De La Taille, Pisters (5) Chin, Long,
De La Taille, Pisters (6) Bahn, Chin
(1) Isawa (2) Chin, Miller (3) Chin
9Local Relapse After RBT Salvage Brachytherapy
- Difficult follow-up nadir PSA gt 36 months
- Small series with short follow-up
- 5ybNED 34 (1)
- Complications
- LUTS 6 (2)
- Urinary incontinence 24 (2)
- Rectal ulcers 4 (1)
- Rectal bleeding with colostomy 2 (1)
(1) Grado (2) Beyer
10Local Relapse After RBT Looking for a Better
Alternative Treatment with Curative Intent
Is HIFU the Solution ?
11Salvage HIFU Post RBT Patient Characteristics
- 1995 2006
- 152 pts with RBT failure
- Age 68,4 6 years
- Pre HIFU
- PSA 7,35 8,03 ng/ml (median 4,86 ng/ml)
- Gleason score
- lt 7 55 patients 7 35 patients gt 7 62
patients - Prostate volume 17,9 8,75 cc (median 18 cc)
- Negative metastatic evaluation
12Salvage HIFU Post RBT Results
- Mean follow-up 17 months 3 120 months
- Retreatment rate 10
- CONTROL BIOPSIES negatives in 76,5
- PSA
- nadir at 3 months post HIFU
pts
pts
pre HIFU PSA median PSA 4.86 ng/ml
post HIFU PSA median PSA 0.19 ng/ml
PSA
ng/ml
ng/ml
13Salvage HIFU After RBT Stratified DFR() by
Pre-RBT Risk Level
Pre RBT risk level (dAmico et al., Cancer, 2002)
Low risk 56()
DFS ()
DFS ()
High risk 9 ()
Medium risk 47()
pts
75 44 29 16 8 4
2
pts
77 31 14 9 9 6
2
() Log rank p0.0004
() Log rank p0.0004
months
() negative biopsy PSAlt1ng/ml and stable no
adjuvant therapy
Ablatherm- HIFU for prostate cancer a 10-year
European experience
A symposium sponsored by
14Salvage HIFU After RBT Protocol Improvements
- 2 periods
- 1995 2002 no specific treatment
parameters for RBT failures (56 patients) ?
complication rate to be improved - 2002 today specific treatment
parameters (96 patients) - ? lower complication rate
15Salvage HIFU After RBT Complications
16Salvage HIFU After RBT Uretro-rectal Fistula
No more uretro-rectalfistulas with the specific
RBTfailure treatment protocol
17Salvage HIFU After RBT
General Conclusions
- Local tumor control in 76.5 of the cases
- Cancer control is higly correlated with the pre
RBT risk level - The lower the risk level, the higher the HIFU
efficacy - ? Patient selection should be based on the pre
RBT level - Complications have decreased with specific
post-radiation treatment parameters - Urinary incontinence dominates
- No uretro-rectal fistula
18Salvage HIFU After RBT
Conclusions for high risk patients
HIFU a valid indication ? Some patients may
benefit from this treatment but they need to be
carefully selected in order to avoid any silent
metastasis ? F18 FC PET Scan benefits?
F18 fluorocholinePET scan
Bone CT
Ablatherm- HIFU for prostate cancer a 10-year
European experience
A symposium sponsored by
19Salvage HIFU After RBT
Conclusions for low / medium risk patients
- HIFU offers for patients with local relapse after
RBT - A high tumor local control
- A high oncological efficacy
- An acceptable morbidity with no UR fistulas with
- the specific RBT failures treatment
parameters -
- ? A major indication for HIFU
- The future gold standard for treatmentof RBT
failures ?